ProfitQuotes.com
symbol lookup  commodity list
Bookmark This Page
Friday's ETF with Unusual Volume: RSPU

Fri, 03 May 16:24:07 GMT
S&P 500 Analyst Moves: CTRA

Fri, 03 May 16:12:25 GMT
Portfolio Channel
Free Energy Dividend Stock Report
Free Dividend Report - Top Ranked Stocks
Free Dividend Paying Gold/Metals Stocks Report
Get a quote box (like the one below) for your site!
ProfitQuotes.com Commodities Quotes
commodity quotes list
energy quotes  gold quotes
uranium stocks  
solar power stocks

wind power stocks

Industry focus:

advertising stocks,
space stocks,
aerospace stock,
aerospace sector,
list of aerospace companies,
largest chemical companies,
chemical stock,
chemical news,
best agriculture stocks,
ag stocks,
chinese agriculture stocks,
top agriculture companies,
agriculture stocks,
agricultural stocks,
agricultural stock,
stocks agriculture,
agriculture markets,
agriculture index,
agriculture industries,
agricultural investment,
agriculture investment,
agricultural industry,
farm stock,
airline stock symbols,
airline stock prices,
airline stock,
airlines stock,
clothing stock,
fashion stocks,
publicly traded fashion companies,
clothing company stocks,
apparel stock,
apparel companies,
application software stocks,
asset management stocks,
auto stocks,
auto industry stocks,
chinese auto stocks,
auto stock prices,
automotive stock,
auto parts stocks,
community bank stocks,
regional bank stocks,
canadian bank stocks,
banking stock,
national bank stocks,
commercial bank stock,
banks stock,
bank stock quote,
bank stocks,
banking industry,
alcohol stocks,
beverage stock,
global wine stocks,
wine stocks,
liquor stock,
biotech stocks list,
biotechnology investing,
public biotech companies,
top biotech stocks,
nanotechnology stock,
largest biotech companies,
biotechnology stock,
biotech investing,
investing in biotech,
best biotech companies,
bio stocks,
biotech sector,
biotechnology investment,
biopharma companies,
new biotech companies,
biotech investment,
biotechnology industries,
nanotech stocks,
biotech stocks,
biotechnology articles,
biotechnology news,
business stocks,
service stocks,
chemical companies,
chemical industries,
chemical industry,
chemical company,
chemicals company,
cigarette stock,
cigarette company stocks,
cigarette stock symbols,
tobacco company stocks,
tobacco stock,
cigar stocks,
communications stocks,
communication stock,
computer peripherals companies,
computer peripherals,
computers stocks,
computer stock,
computer web,
internet stocks,
construction stocks,
machinery stocks,
builders stocks,
building stocks,
consumer goods stocks,
consumer services stocks,
consumer services companies,
lending stocks,
mortgage banking,
lending companies,
mortgage bankers,
loan services,
mortgage services,
mortgage bank,
loan bank,
defense stocks,
defensive stock,
department store stocks,
diagnostic company,
diagnostic companies,
pharmaceuticals stocks,
drug stocks,
drug company stocks,
pharma stock,
education stocks,
college stock,
electric utility stocks,
electric company stocks,
electric utilities stocks,
utility stocks,
utilities stocks,
power equipment companies,
electrical supply companies,
electronic stocks,
entertainment stock,
movie stocks,
movies companies,
movie company,
cefs,
open ended and closed ended mutual funds,
closed ended investment,
closed ended fund,
bonds fund,
closed end,
food stock,
game stock,
gambling stocks,
casino stocks,
gaming stocks list,
gaming stocks,
gas utility companies,
gas company stocks,
construction industries,
builders contractors,
construction services,
construction industry,
grocery store stocks,
supermarket stock,
drug store stocks,
home stocks,
furniture stock,
home improvement stocks,
medical company stocks,
top medical stocks,
medical stock,
hospital stock,
medical supply stocks,
medical technology stocks,
medical device stocks,
medical equipment stocks,
copper mining,
palladium mining stocks,
mining metals,
mining,
mining news,
gold exploration,
mining share price,
lithium mines,
mining industries,
international mining companies,
mining information,
molybdenum mining companies,
nickel mining companies,
metals and mining stocks,
gold and silver mining stocks,
copper mining companies,
rare earth mining companies,
rare metals stocks,
rare earth stocks,
metals stocks,
welding stock,
nonprecious metals,
non metallic mining,
office supplies companies,
office supply companies,
oil services stocks,
oil pipeline stocks,
gas pipeline stocks,
gas pipeline companies,
pipeline companies,
natural gas pipeline companies,
oil services companies,
oil field services,
oil service stocks,
natural gas pipelines,
oilfield service companies,
oil and gas pipeline companies,
oil gas pipeline,
oil exploration stocks,
oil exploration sector,
oil exploration companies,
oil drilling stocks,
oil drilling companies,
oil production companies,
china oil companies,
brazil oil companies,
china oil stocks,
brazil oil stocks,
oil companies,
oil stocks,
oil drilling,
oil exploration,
offshore oil drilling companies,
list of oil drilling companies,
oil and gas exploration,
oil and gas drilling,
oil and gas stocks,
oil and gas drilling companies,
oil refining companies,
oil marketing companies,
oil refining stocks,
oil refining sector,
oil refinery companies,
oil refinery stocks,
major oil companies,
oil sector,
oil refinery,
oil refinery company,
oil company,
oil marketing company,
oil refining company,
oil refining industry,
major oil companies list,
oil and gas companies,
crude oil stocks,
packaging companies,
container companies,
packaging stocks,
packaging sector,
container sector,
pulp stocks,
paper stocks,
timber stocks,
pulp companies,
paper companies,
timber companies,
timber trusts,
cardboard companies,
paper sector,
timber sector,
paper companies list,
silver mining companies,
gold mining companies,
gold mining sector,
precious metal stocks,
mining companies,
exploration sector,
mining sector,
exploration stocks,
mining stocks,
silver stocks,
gold stocks,
gold mining stocks,
silver mining stocks,
silver mining company,
canadian mining companies,
gold mining,
gold mining company,
mining company,
list of mining companies,
gold stocks list,
largest gold mining companies,
silver mining,
printing companies,
printing stocks,
printing sector,
newspaper stocks,
newspaper sector,
newspaper companies,
publishing stocks,
publishing sector,
publishing companies,
digital media companies,
digital media stocks,
digital media sector,
book publishing companies,
digital media company,
publishing company,
railroad stocks,
railroad sector,
railroad companies,
railroad company,
railroad investment,
major railroad companies,
real estate companies,
real estate stock,
real estate public companies,
real estate investing,
real estate investments,
real estate sector,
commercial real estate investing,
real estate investment firms,
real estate investing guide,
REITs,
real estate investment trust,
REIT sector,
REIT stocks,
REITs sector,
REITs stock,
public REITs,
real estate investment trusts,
real estate investment trust companies,
real estate investment trusts REITs,
real estate investment companies,
real estate investment company,
real estate investment trust REIT,
rubber stocks,
plastic stocks,
rubber companies,
plastic companies,
rubber sector,
plastic sector,
plastic manufacturing companies,
rubber company,
plastic company,
semiconductor stocks,
semiconductor investments,
semi stocks,
semiconductor companies,
semiconductor sector,
shipping stocks,
dry bulk stocks,
container stocks,
dry bulk shipping,
dry bulk shipping companies,
tanker stocks,
shipping companies,
shipping sector,
specialty retail,
retail stocks,
retail investing,
retail store stocks,
consumer stocks,
consumer investment,
retail companies,
retail sector,
sports stocks,
sports investing,
sporting goods stocks,
sports investments,
sporting goods companies,
sporting goods sector,
stock message boards,
television stocks,
television investment,
radio stocks,
radio invest,
media stocks,
media invest,
media investment,
media investing,
television companies,
television sector,
radio sector,
radio companies,
media companies,
media sector,
textile stocks,
apparel stocks,
textile investment,
textile companies,
textile sector,
apparel sector,
freight investment,
transportation investment,
truck investment ,
freight stocks,
transportation stocks,
trucking stocks,
trucking companies,
trucking sector,
waste management stocks,
waste stocks,
recycling stocks,
waste investment,
waste companies,
waste sector,
water stocks,
water utilities,
water investing,
water investment,
water companies,
water sector

Home Oil & Gas Electricity Metals Treasuries Stocks My Portfolios Forex
News - Full Story Electroceuticals/Bioelectric Medicine Market to Reach $40.5 Billion, Globally, by 2032 at 7.4% CAGR: Allied Market Research

Increasing prevalence of chronic diseases, advancements in technology, and rising demand for non-invasive therapies drive the growth of the global electroceuticals/bioelectric market.

PORTLAND, Ore., April 23, 2024 /PRNewswire/ -- Allied Market Research published a report, titled, "Electroceuticals/Bioelectric Medicine Market by Product (Cardiac Pacemakers and Implantable Cardioverter Defibrillators, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators, Others), by Device Type (Implantable Devices, Non-invasive Devices), by Application (Arrhythmia, Sensorineural Hearing Loss, Epilepsy, Parkinson's Disease, Others), by End User (Hospitals, Ambulatory Surgical Centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032". According to the report, the global electroceuticals/bioelectric medicine market was valued at $ 19.8 billion in 2022 and is estimated to reach $40.5 billion by 2032, exhibiting a CAGR of 7.4% from 2023 to 2032.

Allied Market Research Logo align=middle

Request Sample of the Report on Electroceuticals/Bioelectric Medicine Market Forecast - https://www.alliedmarketresearch.com/request-sample/A07649

Prime determinants of growth

Growing adoption of electroceuticals, advancements in technologies and presence of key players are the factors that drive the growth of the global electroceuticals/bioelectric medicine market. However, high cost of the electroceutical therapy is anticipated to hinder market growth. On the contrary, a rise in healthcare expansion is expected to offer remunerative opportunities for the electroceuticals/bioelectric medicine market during the forecast period.

Report coverage & details:

Report Coverage

Details

Forecast Period

2023-2032

Base Year

2022

Market Size in 2022

$19.8 billion

Market Size in 2032

$40.5 billion

CAGR

7.4 %

No. of Pages in Report

275

Segments covered

Product, Device Type, Application, End User and Region

Regional scope

North America, Europe, Asia Pacific, LA and MEA

Country scope

U.S., Canada; Mexico; Germany; UK; France; Italy; Spain; China; Japan; India; South Korea; Australia; Brazil; Colombia; Argentina; GCC; South Africa; North Africa.

Drivers

Increasing prevalence of chronic diseases

Advancements in technology

Rising demand for non-invasive therapies

Opportunities

Growth opportunity in emerging markets

Restraints

High cost associated with electroceuticals therapy

Want to Explore More, Connect to our Analyst- https://www.alliedmarketresearch.com/connect-to-analyst/A07649

The cardiac pacemakers & implantable cardioverter defibrillators segment to maintain its lead position during the forecast period.

Based on product, the cardiac pacemakers & implantable cardioverter defibrillators segment accounted for the largest share in 2022, accounting for almost two-thirds of the global electroceuticals/bioelectric medicine market revenue. This is primarily attributed to the increasing incidence of cardiovascular diseases like arrhythmias and heart failure, continuous innovations in cardiac device technology, expanding aging demographic, and heightened awareness regarding cardiovascular health and advanced treatment alternatives. These factors collectively contribute to the segment's continued dominance in revenue generation.

However, the deep brain stimulators segment is projected to register highest CAGR of 11.0% during the forecast period owing to increasing R&D activities in neurostimulation therapies for conditions such as essential tremor, dystonia and parkinson's disease. Innovations in technology and expanded indications are driving adoption. Moreover, the growing prevalence of neurological disorders and the demand for non-pharmacological treatment options further fuel the segment's accelerated growth.

The implantable devices segment to maintain its lead position during the forecast period.

Based on device type, the implantable devices segment accounted for the largest share in 2022, accounting for more than four- fifths of the global electroceuticals/bioelectric medicine market revenue. This is primarily attributed to factors such as prolonged service life of implantable device, which reduce the need for frequent replacements and boost cost-effectiveness. Moreover, continuous technological advancements enhance device durability and performance, thus driving the segment growth.

However, the non-invasive devices segment is projected to register highest CAGR of 9.2% during the forecast period owing to growing adoption of minimally invasive treatments, coupled with advancements in technology, making non-invasive devices more effective. In addition, rising demand for home healthcare solutions and expanding applications across various medical specialties contribute to the segment's accelerated growth.

The arrhythmia segment to maintain its lead position during the forecast period.

Based on application, the arrhythmia segment accounted for the largest share in 2022, accounting for almost two-thirds of the global electroceuticals/bioelectric medicine market revenue. This is primarily attributed to increasing prevalence of arrhythmias globally. Factors such as aging population, lifestyle changes, and advancements in arrhythmia management technologies contribute to sustained demand for diagnostic and treatment solutions in this segment.

However, the epilepsy segment is projected to register highest CAGR of 12.1% during the forecast period owing to the rising prevalence of epilepsy worldwide and increasing adoption of deep brain stimulation as an effective treatment option for drug-resistant epilepsy, contributing to the segment's accelerated growth trajectory.

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/A07649

The hospitals segment to maintain its lead position during the forecast period.

Based on end user, the hospitals segment accounted for the largest share in 2022, accounting for more than three-fifths of the global electroceuticals/bioelectric medicine market revenue. This is primarily attributed to the fact that hospitals play a central role in providing comprehensive healthcare services, thus increasing patient admissions. Moreover, advancements in medical technology requiring hospital infrastructure and government policies incentivizing hospital-based care significantly contribute toward the growth of the market.

However, the ambulatory surgical centers segment is projected to register highest CAGR of 8.0% during the forecast period owing to the increasing demand for outpatient procedures, advancements in minimally invasive surgery techniques, and cost-effectiveness compared to traditional hospital settings. Moreover, favorable reimbursement policies and convenience for patients drive the segment's accelerated growth trajectory.

North America to maintain its dominance by 2032

Based on region, North America held the highest market share in terms of revenue in 2022, accounting for more than two-fifths of the global electroceuticals/bioelectric medicine market revenue owing to presence of well-established healthcare infrastructure, robust R&D activities, high adoption rates of advanced medical devices, and favorable reimbursement policies. Moreover, increasing incidence of chronic diseases drive the demand for minimally invasive therapeutic solutions in the region, ensuring sustained market growth.

However, the Asia-Pacific segment is projected to register highest CAGR of 9.8% during the forecast period. This is attributed to the increasing prevalence of chronic diseases, rising healthcare expenditure, expanding access to healthcare services, growing awareness about early disease detection, and ongoing advancements in therapeutic technologies.

Leading Market Players: -

  • Medtronic
  • Abbott Laboratorie
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • LivaNova PLC
  • Biotronik SE & Co. KG
  • ElectroCore, Inc.
  • Sonova
  • Nevro Corp.
  • Stimwave LLC.

The report provides a detailed analysis of these key players of the global electroceuticals /bioelectric medicine market. These players have adopted different strategy such product launch, product development, and product approval to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int'l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg

Cision src=https://c212.net/c/img/favicon.png?sn=IO94772&sd=2024-04-23 View original content:https://www.prnewswire.com/news-releases/electroceuticalsbioelectric-medicine-market-to-reach-40-5-billion-globally-by-2032-at-7-4-cagr-allied-market-research-302124096.html

SOURCE Allied Market Research

<  back


TickerTech.com Private-label branded pages powered by TickerTech.com. Copyright © 2024 Ticker Technologies, All Rights Reserved. Quote data is at least 20 minutes delayed. NYMEX/COMEX data is at least 30 minutes delayed. Please read other important disclaimer information.
"Put First Things First! These four words cover an entire philosophy which can be applied with profit by every business leader, by every executive and by every employee." - Thomas Watson
Google
 

© Ticker Technologies, all rights reserved. Profitquotes.com is wholly owned by Ticker Technologies and serves to demonstrate the company's products to prospective clients. All quotes are in US Eastern Time (EST) and delayed at least 15 minutes. NYMEX/COMEX data delayed at least 30 minutes. Data is presented for informational purposes only and not intended for investment purposes. Nothing on this site should be considered advice, opinions, recommendations, or endorsements from ProfitQuotes.com or TTI Group. Full Disclaimer.